Ventilator-associated pneumonia rates and use of SRLF 2017 diagnostic rules in an ICU (2022–2024)

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a retrospective observational review of respiratory samples and clinical records from mechanically ventilated adult patients cared for in a single regional ICU between January 1, 2022 and December 31, 2024. Patients included are adults intubated and ventilated for more than 48 hours with a positive respiratory sample, excluding organ donors and patients with therapeutic limitation decisions. Clinical and radiological data will be compared to the 2017 SRLF diagnostic criteria to determine whether those criteria were applied and to measure VAP incidence in this population. Results will include adherence rates to SRLF guidance, patterns of microbiology, and descriptive information on antibiotic use and ventilation duration.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults ≥ 18 years
* Hospitalization in Intensive care unit for the period between 01/01/2022 and 31/12/2024
* Intubation and mechanical ventilation for \> 48h
* Positive respiratory sample

Exclusion Criteria:

* Decision of therapeutic limitation
* Organ donors
* Patient refuse to participate

Where it's running

• Centre Hospitalier Sud Francilien
  Corbeil-Essonnes, France, France Recruiting

Study contacts

• Principal investigator: Luis ENSENYAT MARTIN, MD — Centre Hospitalier Sud Francilien
• Study coordinator: Luis ENSENYAT MARTIN, MD
• Email: luis.ensenyatmartin@chsf.fr
• Phone: 33 1 61 69 31 57

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Reducing ventilator-associated pneumonia in newborns in the NICU

  This project will see if training NICU teams and using standardized care protocols can lower ventilator-associated pneumonia in babies on mechanical ventilation.

  Recruiting at 34 sites Biobizkaia Health Research Institute · A Coruña, A Coruña and 38 other locations · NCT07240038

• Antibiotic approaches for Stenotrophomonas maltophilia pneumonia in ICU patients

  This study tests whether using one antibiotic versus two, and whether treating for 7 days versus 14 days, helps adults on ventilators in the ICU with Stenotrophomonas maltophilia pneumonia survive and avoid recurrence.

  Recruiting Centre Hospitalier de Saint-Denis · Saint-Denis, France · NCT07052604

• Examining immunity markers in ICU patients with ventilator-associated pneumonia

  This study is trying to see if measuring certain immune markers in ICU patients with ventilator-associated pneumonia can help improve their treatment and outcomes.

  Recruiting Centre Hospitalier Intercommunal Aix-Pertuis · Aix-en-Provence · NCT06607055

• Using sequencing to predict outcomes of pneumonia in ventilated patients

  This study is testing if analyzing germs in the lungs of patients on ventilators can help predict how well they will recover from pneumonia.

  Recruiting The First Affiliated Hospital with Nanjing Medical University · Nanjing, Jiangsu · NCT06467864

• Using interferon gamma to treat pneumonia in ICU patients on ventilators

  This study is testing if a treatment called interferon gamma can help improve recovery for adults on ventilators who have pneumonia while in the ICU.

  Recruiting at 4 sites Phase 3 Hospices Civils de Lyon · Limoges and 8 other locations · NCT05843786

• Strategy using bacterial DNA detection to guide antibiotics in immunocompromised patients with ventilator-associated or hospital-acquired pneumonia

  This study tests whether using a PCR-based method to tailor antibiotics in immunocompromised ICU patients with suspected VAP or HAP on mechanical ventilation can improve the use of targeted antibiotics within 24 hours of diagnosis.

  Recruiting University Hospital, Lille · Lille · NCT05405491

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.